Clinical Trial Update: Intraocular Anti-VEGF Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema [Phase 4]

View source ↗

Summary

Phase 4 study comparing intraocular anti-VEGF therapy with intraocular triamcinolone for diabetic macular edema; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Intraocular anti-VEGF therapy
• Triamcinolone acetonide (intraocular) (triamcinolone acetonide)

Snippet

Sponsor: Medical University of Vienna | Conditions: Diabetic Macular Edema | Phase 4 | Status: COMPLETED | Results posted: 2016-04-04